# Abbott Laboratories (ABT) — Q4-2017 Earnings Results

**Report date:** 2018-01-24 (before market open)  
**Sector:** Health Care / Health Care Equipment  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/ABT/earnings/Q4-2017

## Post-Earnings Brief

### Headline

Abbott Labs Misses on EPS, Stock Up 4.20%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.74 | N/A | -0.07% |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed satisfaction with the quarter's performance despite missing EPS expectations. They emphasized a commitment to innovation and growth.

**Key quotes:**

> We are pleased with our overall performance this quarter.

> Our focus remains on innovation and expanding our product offerings.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Abbott Labs reported an EPS of $0.74, slightly missing expectations, but the stock rose 4.20% in reaction. This increase may reflect investor confidence in the company's long-term growth strategy and management's positive outlook despite the EPS miss. The lack of revenue data and guidance may leave some investors cautious moving forward.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/ABT/earnings/Q4-2017_